Wang and colleagues conducted further research and discovered that IGFBP7 promotes the progression of NAFLD by inducing ferroptosis through NCOA4-mediated ferritinophagy. Here, IGFBP7 is linked to metabolic dysfunction-associated steatotic liver disease.